Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.0177 EUR
298.90 M EUR
3.36 B EUR
9.64 B
About SINO BIOPHARMACEUTICAL
Sector
CEO
S Y Tse
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG000CBMKG5
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SINO BIOPH.SUBDIV.HD-,025 stocks are traded under the ticker SMZ1.
We've gathered analysts' opinions on SINO BIOPH.SUBDIV.HD-,025 future price: according to them, SMZ1 price has a max estimate of 0.84 EUR and a min estimate of 0.35 EUR. Watch SMZ1 chart and read a more detailed SINO BIOPH.SUBDIV.HD-,025 stock forecast: see what analysts think of SINO BIOPH.SUBDIV.HD-,025 and suggest that you do with its stocks.
SMZ1 reached its all-time high on Jul 23, 2020 with the price of 1.2900 EUR, and its all-time low was 0.0015 EUR and was reached on Feb 26, 2009. View more price dynamics on SMZ1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track SINO BIOPH.SUBDIV.HD-,025 financials in yearly and quarterly reports right on TradingView.
SINO BIOPH.SUBDIV.HD-,025 is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
SMZ1 earnings for the last half-year are 0.01 EUR per share, whereas the estimation was 0.01 EUR, resulting in a 9.43% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about SINO BIOPH.SUBDIV.HD-,025 earnings.
SINO BIOPH.SUBDIV.HD-,025 revenue for the last half-year amounts to 2.04 B EUR, despite the estimated figure of 1.95 B EUR. In the next half-year revenue is expected to reach 2.01 B EUR.
SMZ1 net income for the last half-year is 186.90 M EUR, while the previous report showed 134.48 M EUR of net income which accounts for 38.98% change. Track more SINO BIOPH.SUBDIV.HD-,025 financial stats to get the full picture.
SINO BIOPH.SUBDIV.HD-,025 dividend yield was 1.44% in 2023, and payout ratio reached 35.95%. The year before the numbers were 2.63% and 75.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 16, 2024, the company has 25.81 K employees. See our rating of the largest employees — is SINO BIOPH.SUBDIV.HD-,025 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINO BIOPH.SUBDIV.HD-,025 EBITDA is 910.02 M EUR, and current EBITDA margin is 25.87%. See more stats in SINO BIOPH.SUBDIV.HD-,025 financial statements.
Like other stocks, SMZ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINO BIOPH.SUBDIV.HD-,025 stock right from TradingView charts — choose your broker and connect to your account.